The Consortium

The AFFECT-EU consortium consists of 26 partners, including, health-care providers (nurses, general practirioners, cardiologists, neurologists) and allied healthcare professionals, social scientists, clinical trialists, health economists (specialists in nutrition, environmental sciences), epidemiologists, biologists, a health insurance, policy-maker and industry. AFFECT-EU is a strong consortium built on an established network and long-term co-operations among its partnes, with the aim of implementing AF screening in clinical practice.

Participant organisation name	Country
University Medical Center Hamburg-Eppendorf [UKE]	Germany
National Institute of Health and Welfare Finland [THL]	Finland
University of Sydney [UNSYD]	Australia
Linköping University [LIU]	Sweden
University of Cambridge [CU]	United Kingdom
University of Oxford [UOXF]	United Kingdom
McMaster University [MAC]	Canada
University of Belgrade [MFUB]	Serbia
Atrial Fibrillation NETwork [AFNET]	Germany
University of Modena and Reggio Emilia [UNIMORE]	Italy
Edinburgh Napier University [NAPIER]	United Kingdom
European Society of Cardiology [ESC]	France
Health Service Executive West [HSE]	Ireland
The Rigshospitalet [REGIONH]	Denmark
Vall d'Hebron Research Institute [VHIR]	Spain
University RWTH Aachen [RWTH]	Germany
Boston University [BU]	United States
University College Cork–National University of Ireland [UCC]	Ireland
University of Amsterdam - Academic Medical Center [AMC]	Netherlands
University of Birmingham [UoB]	UK
Roche Diagnostics [ROCHE]	Switzerland
Umea University [UMU]	Sweden
Tromsø University [UIT]	Norway
Pfizer Pharma GmbH [PZIFER]	Germany
Mediterranean Neurological Institute [NEUROMED]	Italy